eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0018799|heart disease |
| Sentences | 7 |
| PubMedID- 23330253 | Increased serum level of lipoprotein-associated phospholipase a2 level, an independent predictor of coronary heart disease, was detected in patients with nonalcoholic fatty liver disease [nafld] in another article. |
| PubMedID- 25796866 | The aim of the research was to evaluate variants of the course of non-alcoholic fatty liver disease in patients with ischemic heart disease and possibilities of safe hypolipidemic therapy. |
| PubMedID- 25629574 | Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease. |
| PubMedID- 23390892 | Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. |
| PubMedID- 24736032 | Objective: the aim of this study is to determine if ultrasonography-diagnosed nafld is associated with prevalent ischemic heart disease (ihd) among patients with diabetes mellitus. |
| PubMedID- 25304010 | Screening of nonalcoholic fatty liver disease in patients with coronary heart disease by transient elastography: proceed with caution. |
| PubMedID- 20835270 | Follow-up mortality rates of nafld patients with coronary heart disease were found to be equal to those attributable to cirrhosis3. |
Page: 1